ClinicalTrials.gg
RecruitingNCT05962372PRECISIONUpdated Jul 28, 2026

Culturally Adapted Dietary Clinical Trial in PR

An interventional study of Culturally tailored food and diet advice and Standard healthy eating advice in Diabetes Mellitus, Type 2, Obesity and Hypertension, sponsored by Harvard School of Public Health (HSPH). Recruiting at 1 site in Puerto Rico. Open to participants aged 30 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-28.

Sponsored by Harvard School of Public Health (HSPH) · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started May 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
30 Years to 65 Years
Sex
All
01

Study summary

This project will determine whether a diet culturally adapted to adults in Puerto Rico can effectively decrease cardiometabolic risk factors. This will help define a culturally-appropriate, feasible, and sustainable diet intervention aimed at reducing cardiovascular, type 2 diabetes, and obesity outcomes.

Read the detailed description

This intervention will culturally tailor a diet to the adult population in Puerto Rico based on staple foods as well as culturally appropriate strategies to reduce cardiometabolic risk factors. Based on preliminary results from studies on the island, investigators will conduct a 24-month, 2-arm intervention among 250-350 adults (125-175 per arm) ages 30-65 living in Puerto Rico with at least 1 of 5 cardiometabolic risk factors. The two arms are (1) intervention group with culturally-tailored portion-control Mediterranean Diet-like advice through monthly individual counseling for 12 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes, vegetable oils, and locally sourced assorted fruit and vegetables for 18 months; (2) control arm with portion-control standard non-tailored nutritional counseling in monthly individual sessions for 12 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18-24, we will monitor behavior maintenance (no food/voucher or counseling), with support from the nutritionist, and cues-to-action texts. Investigators will measure changes in cardiometabolic risk factors and metrics of eating behaviors and psychological factors. The two co-primary outcomes are changes in ASCVD score and cardiometabolic improvement score.

02

Conditions studied

  • Diabetes Mellitus, Type 2
  • Obesity
  • Hypertension
  • Dyslipidemias
  • High Triglycerides
  • High Blood Glucose
  • Abdominal Obesity
03

In context

Diabetes Mellitus, Type 2

10,371 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,406 are open to participants now.

This study's planned enrollment of 250 is above the median of 80 across 8,350 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

Harvard School of Public Health (HSPH) is the lead sponsor of 154 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 30-65y old at the time of enrollment
  2. Non-institutionalized
  3. Living in PR at the time of recruitment and for at least the previous year and not planning to move from the island within the next 3 years
  4. Able to answer questions without assistance
  5. Having a cellphone with the capacity to receive text messages and be willing to receive daily text messages from the study on the designated cellphone number
  6. Having at least one of the following:

    1. elevated
    2. elevated waist circumference
    3. self-reported physician-diagnosed hypertension or use of hypertension medication or measured high blood pressure at the baseline visit
    4. self-reported physician-diagnosed pre-diabetes or measured pre-diabetes at the baseline visit
    5. self-reported physician-diagnosed dyslipidemia or use of lipid-lowering agents or laboratory values confirming dyslipidemia

Exclusion criteria

Exclusion Criteria:

  1. Under 30 or over 65 years of age (on the day of the interview).
  2. Currently not living in Puerto Rico or not lived on the island for at least 1 year or planning to move within 3 years
  3. Institutionalized
  4. Not able to answer questions without assistance
  5. Not having at least 1 of the five listed metabolic criteria
  6. Self-reported physician-diagnosed type 1 or type 2 diabetes or use of diabetes medication (including insulin) or diabetes-diagnosis values confirmed by laboratory
  7. Self-reported pregnancy
  8. Gastrointestinal or chronic condition that would impact eating behaviors or nutritional status
  9. Intolerance or allergies to legumes (i.e.: beans and nuts), vegetable oils (i.e.: corn, olive, canola), or fresh produce
  10. Living with another person participating in the study
  11. Participating in another research study that conflicts with PRECISION
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
250 participants (estimated)

Study arms

  • Experimental
    Intervention

    Intervention group will receive culturally-tailored portion-control Mediterranean-like advice through monthly individual counseling for 6 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes (i.e., beans and peanuts), vegetable oils (i.e., olive oil + a blend of canola and soybean), and locally sourced assorted fruit and vegetables for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no food or counseling) with support from the nutritionist available.

    Behavioral: Culturally tailored food and diet advice

  • Active comparator
    Control

    Control group will receive portion-control standard non-tailored nutritional counseling in monthly individual sessions for 6 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no voucher or counseling), with support from the nutritionist available.

    Behavioral: Standard healthy eating advice

Interventions

  • BehavioralCulturally tailored food and diet advice

    Puerto Rico-tailored education includes strategies for healthy eating, preferences for traditional healthy foods, recommendations for limiting unhealthy traditional foods, portion sizes, etc.

  • BehavioralStandard healthy eating advice

    Standard healthy eating education includes strategies, foods, portions, and cooking and eating tips included in the My Plate For A Healthy Puerto Rico dietary recommendations.

06

What researchers measure

Primary outcomes

  1. 10-year risk score for a first atherosclerotic CVD event (ASCVD score)

    Estimate the change in first atherosclerotic CVD event (ASCVD) score; the score is calculated using the Pooled Cohort Equation which accounts for biological sex, age, race, total cholesterol, HDL-C, systolic blood pressure, treatment for high blood pressure, current diabetes diagnosis, and smoking status. Scores are expressed as percentage (0-100) with higher scores indicative of higher 10-year risk for ASCVD event. It is categorized as low-risk \<5%; borderline risk 5% to 7.4%; intermediate risk 7.5% to 19.9%; and high risk ≥20%.

    Time frame: 6; 12; 18; 24 months

  2. Cardiometabolic Improvement Score (CIS)

    Estimate the change in the score; calculated as the added number of risk factors changed over a predefined value; range of 0 to 10; from less to more improvement.

    Time frame: 6; 12; 18; 24 months

Secondary outcomes

  1. Changes in diet quality score

    Determine the change in score of short diet quality screener (range 18-54; from lowest to highest quality)

    Time frame: 6; 12; 18; 24 months

  2. Changes in diet satisfaction: diet satisfaction scale

    Determine the change in the score of the Diet Satisfaction Questionnaire (DSat-45) (range 45-225; from lowest to highest satisfaction) and its summed seven subscales (ranges 5-40)

    Time frame: 6; 12; 18; 24 months

  3. Changes in intake of pre-specified food groups (fruit; vegetables; legumes; oils; meat; fat)

    Determine the change in servings/week of food groups

    Time frame: 6; 12; 18; 24 months

  4. Change in levels of waist circumference

    Estimate the change in the value of waist circumference (cm)

    Time frame: 6; 12; 18; 24 months

  5. Change in levels of BMI

    Estimate the change in the value of body mass index (kg/m2)

    Time frame: 6; 12; 18; 24 months

  6. Change in levels of blood pressure risk factors

    Estimate the change in the value of systolic and diastolic blood pressure (mmHg)

    Time frame: 6; 12; 18; 24 months

  7. Change in levels of metabolic risk factors

    Estimate the change in the value of glucose, triglycerides, total cholesterol, LDL, HDL (mg/dL)

    Time frame: 6; 12; 18; 24 months

  8. Change in food security status

    Estimate the change in food security status assessed by the USDA Food Security Module

    Time frame: 6; 12; 18; 24 months

  9. Change in self-efficacy score

    Estimate the change in self-efficacy score assessed by the Nutritional Self-Efficacy Scale

    Time frame: 6; 12; 18; 24 months

Other outcomes

  1. Change in social connectedness score

    Estimate the change in social connectedness score from the Social Connectedness Scale/Social Assurance Scale

    Time frame: 6; 12; 18; 24 months

  2. Change in social support score

    Estimate the change in social support score from the 12-item Social Support Scale

    Time frame: 6; 12; 18; 24 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — IPD will be managed and distributed observing NIH and IRB policies on the dissemination and sharing of research results. Study information and requests for data will be available immediately upon the data being de-identified and properly revised for quality control by contacting study investigators.

Supporting information: Study protocol, Informed consent form

Time frame: 10 years

Access criteria: The requested data will be shared with investigators via a secured, password-protected software website, upon request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for May 2029, 60 months after the start.

Of 2,066 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 60 months is above that.

Counting every sponsor, half of 2,243 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2023
First posted
Jul 27, 2023
StartActual
May 2, 2024
Primary completionEst.
May 2, 2029
CompletionEst.
May 2, 2029
Last update
Jul 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05962372
Collaborators
Yale University, Broad Institute of MIT and Harvard, Puerto Rico Consortium for Clinical Investigations
Responsible party
Josiemer Mattei (Professor of Nutrition, Harvard School of Public Health (HSPH)) — Principal investigator
First posted
Jul 27, 2023
Start date
May 2, 2024
Primary completion
May 2, 2029 (estimated)
Completion
May 2, 2029 (estimated)
Last update
Jul 28, 2026

Study contacts

Natalia Torres, BS
Contact
natalia.torres@prcci.org
787-523-1593
Josiemer Mattei, PhD, MPH
principal investigator · Harvard Chan School of Public Health
Amarilys F Sylva, PhD
study director · Puerto Rico Consortium for Clinical Investigations

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion